2017 Acta Pharmaceutica Sinica B Highly Cited Papers

摘要

1. HIF-1α pathway: role, regulation and intervention for cancer therapy Acta Pharm Sin B 2015; 5: 378-389(Georgina N. Masoud, Wei Li) 2. Mechanisms of resistance to EGFR tyrosine kinase inhibitors Acta Pharm Sin B 2015; 5: 390-401(Lihua Huang, Liwu Fu) 3. Cancer metastases: challenges and opportunities Acta Pharm Sin B 2015; 5: 402-418(Xiangming Guan)